ACADIA Pharmaceuticals Inc. is a company in the U.S. stock market and it is a holding in 67 U.S.-traded ETFs. ACAD has around 9.6M shares in the U.S. ETF market. The largest ETF holder of ACAD is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.60M shares. Investors may also find of interest that the ETF with the largest allocation to ACAD stock is First Trust NYSE Arca Biotechnology Index Fund (FBT), with a portfolio weight of 3.41%. On average, U.S. ETFs allocate 0.36% of ACAD to their portfolios.
Additionally, ACAD is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ACAD as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.